Market Narratives
Market themes driving price action · Updated Jul 25, 2026
TYMZambia silver exploration
An article belongs to this narrative if it discusses Tertiary Minerals' silver exploration in Zambia.
JPMorgan Chase & Co. CEO expects 2026 loan growth to exceed industry average
An article belongs to this narrative if it discusses JPMorgan Chase's expected loan growth in 2026.
WALMChicago Bulls minority stake
An article belongs to this narrative if it discusses Lukas Walton's minority stake purchase in the Chicago Bulls and United Center.
CODI.PRBCOMPASS preferred shares yield
An article belongs to this narrative if it discusses Compass Diversified's Series B Preferred Shares yield.
VMC unusual options activity
An article belongs to this narrative if it discusses unusual options activity involving Vulcan Materials Co (VMC).
Florida closes 'Alligator Alcatraz' immigrant holding center
An article belongs to this narrative if it discusses the closure of Florida's 'Alligator Alcatraz' immigrant holding center.
BHR ex-dividend reminder for Series B Preferred Stock
An article belongs to this narrative if it discusses Braemar Hotels & Resorts' Series B Preferred Stock going ex-dividend.
Maze Therapeutics CEO Jason Coloma sells over 30,000 shares
An article belongs to this narrative if it discusses significant insider trading activity involving Maze Therapeutics.
KeyBanc raises price target on Arista Networks stock
An article belongs to this narrative if it discusses KeyBanc's upgrade of Arista Networks' stock price target.
DuPont de Nemours analyst report
An article belongs to this narrative if it discusses DuPont de Nemours' analyst report.
Bond ETF expense ratio comparison
An article belongs to this narrative if it compares expense ratios of different bond ETFs.
Air Force One replacement
An article belongs to this narrative if it discusses the replacement or unveiling of the new Air Force One plane.
Dr Reddy's semaglutide supply delay
An article belongs to this narrative if it discusses the supply delay of semaglutide by Dr Reddy's Laboratories.
IMMX insider sells 32% stake before FDA milestone
An article belongs to this narrative if it discusses significant insider selling at Immunome before a major FDA event.
UCTT CAO sells shares after strong Q1 revenue
An article belongs to this narrative if it reports an insider selling shares at Ultra Clean Holdings after a positive earnings report.
Citadel boosts stake in dividend king
An article belongs to this narrative if it discusses Ken Griffin's significant investment in a dividend-paying company.
RUM insider buying
An article belongs to this narrative if it discusses Rumble Inc. insider buying activity.
Market update: ADTN, WMT, SNAP, PINS
An article belongs to this narrative if it provides a market update, including the mentioned tickers.
CDW surpasses VICI Properties in analyst rank
An article belongs to this narrative if it discusses CDW Corp surpassing VICI Properties in analyst recommendations.
US consumer sentiment improves
An article belongs to this narrative if it reports on changes in US consumer sentiment.
Connected TV vs. Southeast Asia e-commerce growth
An article belongs to this narrative if it compares the growth prospects of connected TV and Southeast Asia e-commerce.
RAAX ETF outflows
An article belongs to this narrative if it reports on outflows from the RAAX ETF.
EPSN CEO buys company stock
An article belongs to this narrative if it reports on EPSN's CEO purchasing company shares.
Unilever's potential Thorne acquisition
An article belongs to this narrative if it discusses Unilever's exploration of acquiring Thorne, a U.S. dietary supplements brand.